Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. SYNA
2. ON
3. SPY
4. MU
5. SPCX
6. AAPL
7. VEON
8. INIO
9. DRI
10. ABBV

Go back to Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study
(NASDAQ: EDSA) Delayed: 8.19 +0.72 (9.64%)
Previous Close $7.47    52 Week High $ 
Open $7.32    52 Week Low $ 
Day High $8.46    P/E N/A 
Day Low $7.32    EPS $ 
Volume 67,948